The CRISPR-cas system promotes antimicrobial resistance in Campylobacter jejuni. [electronic resource]
Producer: 20190506Description: 1757-1774 p. digitalISSN:- 1746-0921
- Anti-Bacterial Agents -- pharmacology
- CRISPR-Associated Protein 9 -- genetics
- CRISPR-Cas Systems -- genetics
- Campylobacter jejuni -- drug effects
- Clustered Regularly Interspaced Short Palindromic Repeats -- genetics
- Drug Resistance, Bacterial -- physiology
- Gene Expression Profiling
- Gene Expression Regulation, Bacterial
- Microbial Sensitivity Tests
- Sequence Deletion
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.